North Growth Management Ltd. Raises Stock Position in Integer Holdings Co. (NYSE:ITGR)

North Growth Management Ltd. grew its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 7.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 99,000 shares of the medical equipment provider’s stock after buying an additional 7,000 shares during the quarter. Integer accounts for approximately 2.4% of North Growth Management Ltd.’s holdings, making the stock its 13th biggest holding. North Growth Management Ltd. owned approximately 0.30% of Integer worth $12,857,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the business. Contravisory Investment Management Inc. raised its stake in shares of Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares during the period. Quest Partners LLC boosted its holdings in Integer by 3,688.9% during the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 332 shares during the period. GAMMA Investing LLC grew its position in Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 142 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Integer in the first quarter worth $106,000. Finally, Innealta Capital LLC bought a new stake in shares of Integer during the second quarter worth $110,000. Institutional investors own 99.29% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Oppenheimer began coverage on shares of Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price on the stock. Benchmark lifted their target price on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. Citigroup raised their price target on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Truist Financial lowered their price objective on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Finally, KeyCorp raised their target price on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $139.75.

Integer Stock Performance

Shares of Integer stock opened at $139.60 on Tuesday. Integer Holdings Co. has a one year low of $84.75 and a one year high of $139.65. The company has a market capitalization of $4.68 billion, a PE ratio of 43.09, a P/E/G ratio of 1.96 and a beta of 1.09. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company has a 50-day simple moving average of $128.43 and a two-hundred day simple moving average of $121.87.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. Integer’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.27 earnings per share. Research analysts expect that Integer Holdings Co. will post 5.33 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.